Castle Biosciences

About:

Castle Biosciences is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer.

Website: http://castlebiosciences.com

Twitter/X: Castle_Biosci

Top Investors: Silicon Valley Bank, Industry Ventures, HealthQuest Capital, Oxford Finance LLC, Mountain Group Capital

Description:

Castle Biosciences is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer. The company also focused on providing physicians and patients with personalized, clinically actionable genomic information to make more accurate treatment plan decisions. The DecisionDx family of molecular diagnostic tests have the ability to meaningfully impact how cancers are diagnosed and managed and the DecisionDx-Melanoma predicts risk of recurrence or metastasis for patients with invasive cutaneous melanoma, a deadly skin cancer, including the risk of sentinel lymph node positivity. Castle Biosciences was founded in 2008 and is headquartered in Friendswood, Texas, United States.

Total Funding Amount:

$428M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Friendswood, Texas, United States

Founded Date:

2008-01-01

Contact Email:

contact(AT)castlebiosciences.com

Founders:

Derek Maetzold

Number of Employees:

501-1000

Last Funding Date:

2020-12-15

IPO Status:

Public

© 2025 bioDAO.ai